APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
70 hedge funds and large institutions have $313M invested in Aptose Biosciences, Inc. in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more funds holding
Funds holding: 65 → 70 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
70
Holding in Top 10
3
Calls
$2.69M
Puts
$1.37M
Top Buyers
| 1 | +$23.9M | |
| 2 | +$13.5M | |
| 3 | +$9.59M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$7.51M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$3.35M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$7.41M | |
| 3 | -$5.14M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$4.04M |
| 5 |
6CM
683 Capital Management
New York
|
-$3.38M |